JW Pharma to use zebrafish in new drug development

JW Pharma to use zebrafish in new drug development

South Korean drug developer JW Pharmaceutical has entered into a memorandum of understanding (MOU) with Zefit, a domestic non-clinical trial institu...

LG Chem to launch new diabetes combination drug Zemidapa

LG Chem to launch new diabetes combination drug Zemidapa

South Korean chemical company LG Chem Ltd. has announced the release of a new diabetes combination drug, Zemidapa Tab, set to launch on Apr. 8. Th...

Drug instructions to be provided via QR codes, URLs in S.Korea

Drug instructions to be provided via QR codes, URLs in S.Korea

South Korea's the Ministry of Food and Drug Safety announced on Friday that it had revised the "Risk Management Plan (RMP) Guidelines" to allow for ...

Kolon Pharma to merge with anti-cancer drug developer Platbio

Kolon Pharma to merge with anti-cancer drug developer Platbio

Kolon Pharma, the pharmaceutical affiliate of South Korea's Kolon Group, is merging with anti-cancer drug developer Platbio to advance the developme...

Biosimilar giant Celltrion to transform into drug developer

Biosimilar giant Celltrion to transform into drug developer

South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...

S.Korea's Biorchestra signs tech transfer deal for drug delivery system

S.Korea's Biorchestra signs tech transfer deal for drug delivery system

Biorchestra Co., a South Korean company specializing in RNA-based therapeutics, announced on Tuesday that it has entered into a joint research and o...

Korea's CJ Bioscience buys drug candidates from 4D pharma of the UK

Korea's CJ Bioscience buys drug candidates from 4D pharma of the UK

South Korea’s pharmaceutical and healthcare company CJ Bioscience Inc. has acquired drug candidates from the UK's 4D pharma plc. to improve co...

Kwangdong introduces new drug candidate for pediatric myopia

Kwangdong introduces new drug candidate for pediatric myopia

South Korean pharmaceutical company Kwangdong Pharmaceutical announced on Monday that it has signed a contract with Hong Kong-based Zhaoke Ophthalmo...

JW Pharma receives 1st overseas patent for its hair loss treatment

JW Pharma receives 1st overseas patent for its hair loss treatment

JW Pharmaceutical, a drug company based in South Korea, has received its first patent for a hair loss treatment that is currently in development. Th...

S.Korea's ST Pharm supplies $49 mn worth of APIs to European drug firm

S.Korea's ST Pharm supplies $49 mn worth of APIs to European drug firm

ST Pharm Co., a South Korean pharmaceutical firm, announced on Thursday that it had entered into an agreement to supply oligonucleotides to an undis...

Samsung Bioepis launches ARMD biosimilar drug in Germany, Canada

Samsung Bioepis launches ARMD biosimilar drug in Germany, Canada

Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...

GC Biopharma introduces candidates for treating blood coagulation disease

GC Biopharma introduces candidates for treating blood coagulation disease

South Korea's GC Biopharma Corp. announced on Tuesday that it had entered into an agreement to transfer assets with Catalyst Biosciences, a US-based...

Celltrion teams up with bio venture to develop new anti-cancer drug

Celltrion teams up with bio venture to develop new anti-cancer drug

South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...

Boryung signs deal with Stendhal to launch hypertension drug in Mexico

Boryung signs deal with Stendhal to launch hypertension drug in Mexico

Boryung, a South Korean pharmaceutical company, said on Monday it had signed a deal with Stendhal SA de CV, a Mexican medical specialty company, to ...

SillaJen starts US trial of anti-cancer drug from Basilea

SillaJen starts US trial of anti-cancer drug from Basilea

SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...

Korea's Daewoong to export diabetes drug Envlo to Brazil, Mexico

Korea's Daewoong to export diabetes drug Envlo to Brazil, Mexico

South Korea’s Daewoong Pharmaceutical Co. said on Feb. 24 it is set to embark on global sales of Envlo, a new drug for diabetes, by exportin...

Korea United Pharm signs contract to supply medicines to Saudi Arabia

Korea United Pharm signs contract to supply medicines to Saudi Arabia

Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...

SK Biopharm holds sales meeting for marketing Cenobamate in US

SK Biopharm holds sales meeting for marketing Cenobamate in US

On Wednesday, SK Biopharmaceuticals Co. announced that its US subsidiary, SK Life Sciences Inc., held a "National Sales Meeting" in San Diego. The p...

HK inno.N's GERD drug K-CAB gets approval in Mexico

HK inno.N's GERD drug K-CAB gets approval in Mexico

South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...

LG Chem builds S.Korea's first plant for clinical trials

LG Chem builds S.Korea's first plant for clinical trials

LG Chem Ltd. has built South Korea’s first pharmaceutical plant dedicated to clinical trials, which the company expects to speed up its medici...

GC Biopharma, Sanofi to jointly market Plavix

GC Biopharma, Sanofi to jointly market Plavix

GC Biopharma Co. (formerly Green Cross Corp.) said on Monday it has entered into a joint sales partnership with Sanofi-Aventis Korea, the South Kore...

Daewoong Pharma wins permission from Singapore for Nabota

Daewoong Pharma wins permission from Singapore for Nabota

South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin...

Hanmi Pharmaceutical reports record-high revenue in 2022

Hanmi Pharmaceutical reports record-high revenue in 2022

South Korea's Hanmi Pharmaceutical Co. last year saw record-high performance thanks to its self-developed drugs, surpassing its previous best year o...

S.Korea's Boryung receives EU GMP certification

S.Korea's Boryung receives EU GMP certification

South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, ...

Chong Kun Dang, Synaffix ink deal to introduce ADC technology

Chong Kun Dang, Synaffix ink deal to introduce ADC technology

Chong Kun Dang Pharmaceutical Corp. said on Monday that it has signed a contract with Dutch biotechnology firm Synaffix B.V for the use of antibody-...

Daewoong receives approval for its GERD drug Fexuclue in Ecuador

Daewoong receives approval for its GERD drug Fexuclue in Ecuador

Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...

Prestige Biopharma submits clinical trial plan in Australia

Prestige Biopharma submits clinical trial plan in Australia

Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US,  has applied to the Australian clini...

Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US

Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US

South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...

Korea's InCerebro to leverage AI to identify drug candidates

Korea's InCerebro to leverage AI to identify drug candidates

South Korean AI-based drug developer InCerebro aims to identify potential drug candidates using molecular modeling technology, according to its CEO ...

S.Korea's Daewoong Pharmaceutical to export tech to British company

S.Korea's Daewoong Pharmaceutical to export tech to British company

South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...

LG links up with Chinese rivals for budget appliance supremacy Mercedes opens world’s 1st Maybach flagship center in Seoul Blackpink's new single Jump tops Spotify daily chart K-content goes cultural: KPop Demon Hunters sparks heritage K-goods craze POSCO supplies HIC-resistant steel for Aramco’s Fadhili gas plant